Retrospective study of Behcet's disease seen at the National Skin Centre, Singapore

Annals of the Academy of Medicine Singapore

Volumn 28, Issue 3, 1999, Pages 440-444

  Tan, Eileen ^a   Chua, S H ^b   Lim, J T E ^b  

^a NATIONAL SKIN CENTRE   (Singapore)

^b NONE

Author keywords

Erythema nodosum; Papulopustular lesions; Pathergy test; Pseudofolliculitis; Recurrent orogenital ulceration

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BEHCET DISEASE; CHRONIC DISEASE; DERMATOLOGY; ETHNOLOGY; FEMALE; HOSPITAL; HUMAN; MALE; MIDDLE AGED; RECURRENT DISEASE; RETROSPECTIVE STUDY; SEX RATIO; SINGAPORE;

ADULT; AGE DISTRIBUTION; BEHCET SYNDROME; CHRONIC DISEASE; DERMATOLOGY; FEMALE; HOSPITALS, SPECIAL; HUMANS; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; SINGAPORE;

EID: 0033126083     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Behcet H. Uber rezidivivierende, aphthose, durch ein irrus verursachte geschwire am Mund, am Ayge und den genitalien. Dermatol Wochenschr 1937; 105:1152-7.
2. International Study Group for Behcet's disease. Criteria for diagnosis of Behcet's disease. Lancet 1990; 335:1078-80.
3. Yazici H, Chamberlain M A, Schreuder I, D'amaro J, Muftuoglu M. HLA antigens in Behcet's disease: a reappraisal by a comparative study of Turkish and British patients. Ann Rheum Dis 1980; 39:344-8.
4. Lewis D A. Behcet's syndrome: a review for the genitourinary medicine physician. Int J STD AIDS 1996; 7:176-83.
5. Ohno S, Ohguchi M, Hirose S, Matsuda M, Wakisaka A, Aizawa M. Close association of HLA Bw51 with Behcet's disease. Arch Ophthalmol 1982; 100:1455-8.
6. Azizlerli G, Aksungur V L, Sarica R, Akyol E, Ovul C. The association of HLA-B5 antigen with specific manifestations of Behcet's disease. Dermatology 1994; 188:293-5.
7. Chong V F H, Pathmanathan R. Familial Behcet's syndrome with intestinal involvement -Case reports and a review of the literature. Ann Acad Med 1993; 22:807-10.
8. Etzioni A. Skin hypersensitivity in Behcet's disease. J Am Acad Dermatol 1989; 21:547-52.
9. Yurdakul S, Yazici H, Tuzun Y, Pazarli H, Yalcin B, Altac M, et al. The arthritis of Behcet's disease: a prospective study. Ann Rheum Dis 1983; 42:505-15.
10. Hamuryudan V, Yurda K W-S, Kural A R, Ince U, Yazici H. Diffuse proliferative glomerulonephritis in Behcet's syndrome. Br J Rheum 1991; 30:63-4.
11. Yurdakul S, Tuzuner N, Yurdakul 1, Hamuryudan V, Yazici H. Amyloidosis in Behcet's syndrome. Arthritis Rheum 1990; 33:1586-9.
12. Jorizzo J L, Hudson R D, Schmalstieg F C, Daniels C, Apisarnthanarax P, Henry C, et al. Behcet's syndrome: immune regulation circulating immune complexes, neutrophil migration and colchicine therapy. J Am Acad Dermatol 1984; 10:205-14.
13. Raynor A, Askari A D. Behcet's disease and treatment with colchicine. J Am Acad Dermatol 1980; 2:396-400.
14. Sharquie K E. Suppression of Behcet's disease with dapsone. Br J Dermatol 1984; 110:493-4.
15. Jorizzo J L, Schmalstieg F C, Solomon A R, Cavallo T, Taylor RS, Rudloff H B. Thalidomide effects in Behcet's syndrome and pustular vasculitis. Arch Int Med 1986; 146:878-81.
16. Ehrlich G E. Behcet's disease and the emergence of thalidomide. Ann Intern Med 1998; 128:494-5.
17. Yazici H, Pazarli H, Barnes C G, Tuzun Y, Ozyagan Y, Silman A. A controlled trial of azathioprine in Behcet's syndrome. N Engl J Med 1990; 322:281-5.